3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
15
Prostatic Neoplasms
10
Neoplasms
6
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Leukemia, Myeloid, Acute
4
Triple Negative Breast Neoplasms
3
Ovarian Neoplasms
3
Myelodysplastic Syndromes
3
Endometrial Neoplasms
3
Colorectal Neoplasms
3
Colonic Neoplasms
3
Cardiovascular Diseases
3
Cardiotoxicity
3
Rectal Neoplasms
2
Polycystic Ovary Syndrome
2
Pancreatic Neoplasms
2
Neoplasm Metastasis
2
Melanoma
2
Lymphoma, Non-Hodgkin
2
Leukemia
2
Kidney Neoplasms
2
Heart Failure
2
Head and Neck Neoplasms
2
Glioblastoma
2
Endometrial Hyperplasia
2
Carcinoma, Renal Cell
2
Waldenstrom Macroglobulinemia
1
Venous Thrombosis
1
Urogenital Neoplasms
1
Smoking
1
Interventions
Blood Specimen Collection
9
Liquid Biopsy
4
cabazitaxel
3
Trastuzumab
3
Surgical Procedures, Operative
3
Propofol
3
Bevacizumab
3
Standard of Care
2
Spinal Puncture
2
Sevoflurane
2
Positron Emission Tomography Computed Tomography
2
Pirinitramide
2
Morphine
2
Laparoscopy
2
Folfox protocol
2
Epirubicin
2
Drug Therapy
2
Cyclophosphamide
2
Cetuximab
2
Carboplatin
2
Aspirin
2
Anesthesia, General
2
ribociclib
1
pertuzumab
1
osimertinib
1
jinfukang
1
eribulin
1
Zoledronic Acid
1
Vinorelbine
1
Thiotepa
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Neoplastic Cells, Circulating
×
Atorvastatin
×
Clear all
NCT02958852
2025-09-10
ABC-SE
Lund University Hospital
Phase 2
Completed
126 enrolled